标题
Systemic Therapy for Merkel Cell Carcinoma: What’s on the Horizon?
作者
关键词
-
出版物
Cancers
Volume 6, Issue 2, Pages 1180-1194
出版商
MDPI AG
发表日期
2014-05-17
DOI
10.3390/cancers6021180
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Efficacy results from a phase I study of lorvotuzumab mertansine (IMGN901) in patients with CD56-positive solid tumors.
- (2017) P. J. Woll et al. JOURNAL OF CLINICAL ONCOLOGY
- T-cell Responses to Oncogenic Merkel Cell Polyomavirus Proteins Distinguish Patients with Merkel Cell Carcinoma from Healthy Donors
- (2014) R. Lyngaa et al. CLINICAL CANCER RESEARCH
- Chronic mTOR activation promotes cell survival in Merkel cell carcinoma
- (2013) Zhenyu Lin et al. CANCER LETTERS
- Merkel Polyomavirus-Specific T Cells Fluctuate with Merkel Cell Carcinoma Burden and Express Therapeutically Targetable PD-1 and Tim-3 Exhaustion Markers
- (2013) O. K. Afanasiev et al. CLINICAL CANCER RESEARCH
- The presence of Merkel cell polyomavirus is associated with deregulated expression ofBRAFandBcl-2genes in non-small cell lung cancer
- (2013) I. Lasithiotaki et al. INTERNATIONAL JOURNAL OF CANCER
- Cabozantinib in Progressive Medullary Thyroid Cancer
- (2013) Rossella Elisei et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical remission of Merkel cell carcinoma after treatment with imatinib
- (2013) Dagmara Ewa Loader et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Response of Merkel Cell Polyomavirus-Positive Merkel Cell Carcinoma Xenografts to a Survivin Inhibitor
- (2013) Lindsay R. Dresang et al. PLoS One
- PD-L1 Expression in the Merkel Cell Carcinoma Microenvironment: Association with Inflammation, Merkel Cell Polyomavirus, and Overall Survival
- (2013) E. J. Lipson et al. Cancer Immunology Research
- Merkel Cell Carcinoma: 30-Year Experience from a Single Institution
- (2012) Juan A. Santamaria-Barria et al. ANNALS OF SURGICAL ONCOLOGY
- Sepantronium Bromide (YM155) induces disruption of the ILF3/p54nrb complex, which is required for survivin expression
- (2012) Tomohiro Yamauchi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- Activation of PI3K Signaling in Merkel Cell Carcinoma
- (2012) Valentina Nardi et al. CLINICAL CANCER RESEARCH
- Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus
- (2012) Scott J. Rodig et al. JOURNAL OF CLINICAL INVESTIGATION
- Systemic Immune Suppression Predicts Diminished Merkel Cell Carcinoma–Specific Survival Independent of Stage
- (2012) Kelly G. Paulson et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Survivin Is a Therapeutic Target in Merkel Cell Carcinoma
- (2012) R. Arora et al. Science Translational Medicine
- Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
- (2012) J. M. Taube et al. Science Translational Medicine
- Bcl-2 expression indicates better prognosis of Merkel cell carcinoma regardless of the presence of Merkel cell polyomavirus
- (2012) Helka Sahi et al. VIRCHOWS ARCHIV
- Suppression of Tumor Invasion and Metastasis by Concurrent Inhibition of c-Met and VEGF Signaling in Pancreatic Neuroendocrine Tumors
- (2012) Barbara Sennino et al. Cancer Discovery
- Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
- (2011) S. A. Rosenberg et al. CLINICAL CANCER RESEARCH
- Transcriptome-Wide Studies of Merkel Cell Carcinoma and Validation of Intratumoral CD8+ Lymphocyte Invasion As an Independent Predictor of Survival
- (2011) Kelly G. Paulson et al. JOURNAL OF CLINICAL ONCOLOGY
- GLA-SE, a Synthetic Toll-like Receptor 4 Agonist, Enhances T-Cell Responses to Influenza Vaccine in Older Adults
- (2011) Hayedeh Behzad et al. JOURNAL OF INFECTIOUS DISEASES
- PD-L2 is expressed on activated human T cells and regulates their function
- (2011) Nassima Messal et al. MOLECULAR IMMUNOLOGY
- A Phase II Trial of Imatinib Mesylate in Merkel Cell Carcinoma (Neuroendocrine Carcinoma of the Skin)
- (2010) Wolfram E. Samlowski et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Combination of temozolomide with immunocytokine F16–IL2 for the treatment of glioblastoma
- (2010) M Pedretti et al. BRITISH JOURNAL OF CANCER
- Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy
- (2010) Gerty Schreibelt et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Remission of Merkel cell tumor after somatostatin analog treatment
- (2010) M Fakiha et al. Journal of Cancer Research and Therapeutics
- KIT receptor activation by autocrine and paracrine stem cell factor stimulates growth of merkel cell carcinoma in vitro
- (2010) Konstantin Krasagakis et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: Analysis of 5823 cases as the basis of the first consensus staging system
- (2010) Bianca D. Lemos et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- G3139 (Genasense) in Patients With Advanced Merkel Cell Carcinoma
- (2009) Manisha H. Shah et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired
- (2009) M. Ahmadzadeh et al. BLOOD
- Response to a Novel Multitargeted Tyrosine Kinase Inhibitor Pazopanib in Metastatic Merkel Cell Carcinoma
- (2009) Matthew Davids et al. JOURNAL OF CLINICAL ONCOLOGY
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- Antibody-Drug Conjugates for Cancer Therapy
- (2008) Paul J. Carter et al. CANCER JOURNAL
- Antibody-Mediated Delivery of Interleukin-2 to the Stroma of Breast Cancer Strongly Enhances the Potency of Chemotherapy
- (2008) J. Marlind et al. CLINICAL CANCER RESEARCH
- Co-Expression of KIT Receptor and Its Ligand Stem Cell Factor in Merkel Cell Carcinoma
- (2008) Konstantin Krasagakis et al. DERMATOLOGY
- Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma
- (2008) Adil I. Daud et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features
- (2008) Michelle Heath et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Nuclear expression of survivin portends a poor prognosis in Merkel cell carcinoma
- (2008) Jinah Kim et al. MODERN PATHOLOGY
- Antitumor effects of somatostatin
- (2008) Stéphane Pyronnet et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma
- (2008) H. Feng et al. SCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started